Filled carbon nanotubes in biomedical imaging and drug delivery

Expert Opinion on Drug Delivery

Volumn 12, Issue 4, 2015, Pages 563-581

  Martincic, Markus ^a   Tobias, Gerard ^a  

^a INSTITUT DE CIÈNCIA DE MATERIALS DE BARCELONA ICMAB CSIC   (Spain)

Author keywords

Carbon nanotubes; Contrast agents; Imaging; Targeted drug delivery; Triggered release

Indexed keywords

ANTINEOPLASTIC AGENT; CARBON NANOTUBE; DNA; PEPTIDE; RNA; DRUG;

BIOCOMPATIBILITY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG TARGETING; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MOLECULE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; THEORETICAL STUDY; ANIMAL; PROCEDURES;

ANIMALS; DIAGNOSTIC IMAGING; DRUG DELIVERY SYSTEMS; HUMANS; NANOTUBES, CARBON; PHARMACEUTICAL PREPARATIONS;

EID: 84925259621     PISSN: 17425247     EISSN: 17447593     Source Type: Journal    
DOI: 10.1517/17425247.2015.971751     Document Type: Review

References (119)

1. Iijima S. Helical microtubules of graphitic carbon. Nature 1991;354:56-8
2. Hou P-X, Liu C, Cheng H-M. Purification of carbon nanotubes. Carbon 2008;46:2003-25
3. Poland CA, Duffin R, Kinloch I, et al. Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nat Nanotechnol 2008;3:423-8
4. Ali-Boucetta H, Nunes A, Sainz R, et al. Asbestos-like pathogenicity of long carbon nanotubes alleviated by chemical functionalization. Angew Chem Int Ed 2013;52:2274-8
5. Shvedova AA, Castranova V, Kisin ER, et al. Exposure to carbon nanotube material: assessment of nanotube cytotoxicity using human keratinocyte cells. J Toxicol and Environ Health 2003;66:1909-26
6. Pulskamp K, Diabate S, Krug HF. Carbon nanotubes show no sign of acute toxicity but induce intracellular reactive oxygen species in dependence on contaminants. Toxicol Lett 2007;168:58-74
7. Kostarelos K. The long and short of carbon nanotube toxicity. Nat Biotechnol 2008;26:774-6
8. Pastorin G. Crucial functionalizations of carbon nanotubes for improved drug delivery: a valuable option? Pharm Res 2009;26:746-69
9. Bianco A, Kostarelos K, Prato M. Making carbon nanotubes biocompatible and biodegradable. Chem Commun 2011;47:10182-8
10. Tasis D, Tagmatarchis N, Bianco A, Prato M. Chemistry of carbon nanotubes. Chem Rev 2006;106:1105-36
11. Heister E, Brunner EW, Dieckmann GR, et al. Are carbon nanotubes a natural solution? Applications in biology and medicine. ACS Appl Mater Interfaces 2013;5:1870-91
12. Vashist SK, Zheng D, Pastorin G, et al. Delivery of drugs and biomolecules using carbon nanotubes. Carbon 2011;49:4077-97
13. Liu Z, Tabakman S, Welsher K, Dai HJ. Carbon nanotubes in biology and medicine: in vitro and in vivo detection, imaging and drug delivery. Nano Res 2009;2:85-120
14. Raffa V, Ciofani G, Vittorio O, et al. Physicochemical properties affecting cellular uptake of carbon nanotubes. Nanomedicine 2010;5:89-97
15. Antonelli A, Serafini S, Menotta M, et al. Improved cellular uptake of functionalized single-walled carbon nanotubes. Nanotechnology 2010;21:425101
16. Allen BL, Kichambare PD, Gou P, et al. Biodegradation of single-walled carbon nanotubes through enzymatic catalysis. Nano Lett 2008;8:3899-903
17. Zhang WX, Zhang ZZ, Zhang YG. The application of carbon nanotubes in target drug delivery systems for cancer therapies. Nanoscale Res Lett 2011;6:555
18. Scheinberg DA, McDevitt MR, Dao T, et al. Carbon nanotubes as vaccine scaffolds. Adv Drug Deliv Rev 2013;65:2016-22
19. Battigelli A, Ménard-Moyon C, Da Ros T, et al. Endowing carbon nanotubes with biological and biomedical properties by chemical modifications. Adv Drug Deliv Rev 2013;65:1899-920
20. Pederson MR, Broughton JQ. Nanocapillarity in fullerene tubules. Phys Rev Lett 1992;69:2689-92
21. Monthioux M, Flahaut E, Cleuziou JP. Hybrid carbon nanotubes: strategy, progress, and perspectives. J Mater Res 2006;21:2774-93
22. Gautam UK, Costa P, Bando Y, et al. Recent developments in inorganically filled carbon nanotubes: successes and challenges. Sci Technol Adv Mat 2010;11:054501
23. del Carmen Giménez-López M, Moro F, La Torre A, et al. Encapsulation of single-molecule magnets in carbon nanotubes. Nat Commun 2011;2:407
24. Vyalikh A, Wolter AUB, Dampel S, et al. A carbon-wrapped nanoscaled thermometer for temperature control in biological environments. Nanomedicine 2008;3:321-7
25. Chuvilin A, Bichoutskaia E, Gimenez-Lopez MC, et al. Self-assembly of a sulphur-terminated graphene nanoribbon within a single-walled carbon nanotube. Nat Mater 2011;10:687-92
26. 2 single-layered inorganic nanotubes encapsulated within carbon nanotubes. Advanced Materials 2014;26:2016-21
27. Liu GR, Cheng Y, Mi D, Li ZR. A study on self-insertion of peptides into single-walled carbon nanotubes based on molecular dynamics simulation. Int J Mod Phys C 2005;16:1239-50
28. Kang Y, Wang Q, Liu YC, et al. Dynamic mechanism of collagen-like peptide encapsulated into carbon nanotubes. J Phys Chem B 2008;112:4801-7
29. Gao HJ, Kong Y, Cui DX, Ozkan CS. Spontaneous insertion of DNA oligonucleotides into carbon nanotubes. Nano Lett 2003;3:471-3
30. Kang Y, Liu YC, Wang Q, et al. On the spontaneous encapsulation of proteins in carbon nanotubes. Biomaterials 2009;30:2807-15
31. Xu J, Tian YS, Peng RH, et al. Cyanobacteria MT gene SmtA enhance zinc tolerance in Arabidopsis. Mol Biol Rep 2010;37:1105-10
32. Agbottah E, Zhang NG, Dadgar S, et al. Inhibition of HIV-1 virus replication using small soluble Tat peptides. Virology 2006;345:373-89
33. Chen BD, Yang CL, Yang JS, et al. Dynamic mechanism of HIV replication inhibitor peptide encapsulated into carbon nanotubes. Curr Appl Phys 2013;13:1001-7
34. Chen BD, Yang CL, Wang MS, Ma XG. Dynamic mechanism for encapsulating two HIV replication inhibitor peptides with carbon nanotubes. Chin Phys B 2012;21:083103
35. Rost KL, Wierich W, Masayuki F, et al. Pharmacokinetics of thymosin alpha 1 after subcutaneous injection of three different formulations in healthy volunteers. Int J Clin Pharm Th 1999;37:51-7
36. Chen Q, Wang Q, Liu YC, et al. Energetics investigation on encapsulation of protein/peptide drugs in carbon nanotubes. J Chem Phys 2009;131:015101
37. Yeh IC, Hummer G. Nucleic acid transport through carbon nanotube membranes. P Natl Acad Sci USA 2004;101:12177-82
38. Chen BD, Yang CL, Yang JS, et al. The translocation of DNA oligonucleotide with the water stream in carbon nanotubes. Comput Theor Chem 2012;991:93-7
39. Arsawang U, Saengsawang O, Rungrotmongkol T, et al. How do carbon nanotubes serve as carriers for gemcitabine transport in a drug delivery system? J Mol Graph Model 2011;29:591-6
40. Rungnim C, Arsawang U, Rungrotmongkol T, Hannongbua S. Molecular dynamics properties of varying amounts of the anticancer drug gemcitabine inside an open-ended singlewalled carbon nanotube. Chem Phys Lett 2012;550:99-103
41. Rungnim C, Rungrotmongkol T, Hannongbua S, Okumura H. Replica exchange molecular dynamics simulation of chitosan for drug delivery system based on carbon nanotube. J Mol Graph Model 2013;39:183-92
42. Ma JG, Murphy M, O'Dwyer PJ, et al. Biochemical changes associated with a multidrug-resistant phenotype of a human glioma cell line with temozolomide-acquired resistance. Biochem Pharmacol 2002;63:1219-28
43. Mollaamin F, Najafi F, Khaleghian M, et al. Theoretical study of different solvents and temperatures effects on single-walled carbon nanotube and temozolomide drug: a QM/MM study. Fuller Nanotub Car N 2011;19:653-67
44. Sornmee P, Rungrotmongkol T, Saengsawang O, et al. Understanding the molecular properties of doxorubicin filling inside and wrapping outside single-walled carbon nanotubes. J Comput Theor Nanos 2011;8:1385-91
45. Stafylas PC, Sarafidis PA. Carvedilol in hypertension treatment. Vasc Health Risk Manag 2008;4:23-30
46. Hilder TA, Hill JM. Modelling the encapsulation of the anticancer drug cisplatin into carbon nanotubes. Nanotechnology 2007;18:275704
47. Mousavi SZ, Amjad-Iranagh S, Nademi Y, Modarress H. Carbon nanotube-encapsulated drug penetration through the cell membrane: an investigation based on steered molecular dynamics simulation. J Membrane Biol 2013;246:697-704
48. Panczyk T, Jagusiak A, Pastorin G, et al. Molecular dynamics study of cisplatin release from carbon nanotubes capped by magnetic nanoparticles. J Phys Chem C 2013;117:17327-36
49. Hosni Z, Bessrour R, Tangour B. 195Pt chemical shift ability to control the antitumor drug cisplatin encapsulated into carbon nanotubes: a theoretical study. J Comput Theor Nanos 2014;11:318-23
50. Rezvani M, Darvish Ganji M, Faghihnasiri M. Encapsulation of lamivudine into single walled carbon nanotubes: a vdW-DF study. Physica E 2013;52:27-33
51. Siegfried NL, Van Deventer PJU, Mahomed FA, Rutherford GW. Stavudine, lamivudine and nevirapine combination therapy for treatment of HIV infection and AIDS in adults. Cochrane Db Syst Rev 2006;CD004535
52. Torii N, Hasegawa K, Ogawa M, et al. Effectiveness and long-term outcome of lamivudine therapy for acute hepatitis B. Hepatol Res 2002;24:34-41
53. Qiu LH, Zhou CL, Sun Y, et al. Paclitaxel and ceramide synergistically induce cell death with transient activation of EGFR and ERK pathway in pancreatic cancer cells. Oncol Rep 2006;16:907-13
54. Belmiloud Y, Ouraghi M, Brahimi M, et al. Theoretical study of the antihuman immuno-deficiency virus TIBO molecule confined into carbon nanotubes. J Comput Theor Nanos 2012;9:1101-8
55. Kawahara S. Chemotherapeutic agents under study. Nihon Rinsho 1998;56:3096-9
56. Chaban VV, Savchenko TI, Kovalenko SM, Prezhdo OV. Heat-driven release of a drug molecule from carbon nanotubes: a molecular dynamics study. J Phys Chem B 2010;114:13481-6
57. Xue QZ, Jing NN, Chu LY, et al. Release of encapsulated molecules from carbon nanotubes using a displacing method: a MD simulation study. R Soc Chem Adv 2012;2:6913-20
58. Giles W, Bisits A. The present and future of tocolysis. Best Pract Res Cl Ob 2007;21:857-68
59. Blanpied TA, Clarke RJ, Johnson JW. Amantadine inhibits NMDA receptors by accelerating channel closure during channel block. J Neurosci 2005;25:3312-22
60. Hicks E, Desgranges C, Delhommelle J. Adsorption and diffusion of the antiparkinsonian drug amantadine in carbon nanotubes. Mol Simulat 2014;40:656-63
61. Saikia N, Jha AN, Deka RC. Dynamics of fullerene-mediated heat-driven release of drug molecules from carbon nanotubes. J Phys Chem Lett 2013;4:4126-32
62. Cui D, Ozkan CS, Ravindran S, et al. Encapsulation of Pt-labelled DNA molecules inside carbon nanotubes. Mech Chem Biosyst 2004;1:113-21
63. Kaneko T, Okada T, Hatakeyama R. DNA encapsulation inside carbon nanotubes using micro electrolyte plasmas. Contrib Plasma Phys 2007;47:57-63
64. Tripisciano C, Costa S, Kalenczuk RJ, Borowiak-Palen E. Cisplatin filled multiwalled carbon nanotubes - a novel molecular hybrid of anticancer drug container. Eur Phys J B 2010;75:141-6
65. Keldsen N, Havsteen H, Vergote I, et al. Altretamine (hexamethylmelamine) in the treatment of platinum-resistant ovarian cancer: a phase II study. Gynecol Oncol 2003;88:118-22
66. Ren YP, Pastorin G. Incorporation of hexamethylmelamine inside capped carbon nanotubes. Adv Mater 2008;20:2031-6
67. 60 molecules. Chem Commun 2008;2164-6
68. Luksirikul P, Ballesteros B, Tobias G, et al. pH-triggered release of materials from single-walled carbon nanotubes using dimethylamino-functionalized fullerenes as removable "corks". Carbon 2010;48:1912-17
69. Vanhoefer U, Harstrick A, Achterrath W, et al. Irinotecan in the treatment of colorectal cancer: clinical overview. J Clin Oncol 2001;19:1501-18
70. Tripisciano C, Rummeli MH, Chen XC, Borowiak-Palen E. Multi-wall carbon nanotubes - a vehicle for targeted Irinotecan drug delivery. Phys Status Solidi B 2010;247:2673-7
71. Li YT, Wang TY, Wang J, et al. Functional and unmodified MWNTs for delivery of the water-insoluble drug Carvedilol - A drug-loading mechanism. Appl Surf Sci 2011;257:5663-70
72. Bisson WH, Cheltsov AV, Bruey-Sedano N, et al. Discovery of antiandrogen activity of nonsteroidal scaffolds of marketed drugs. P Natl Acad Sci USA 2007;104:11927-32
73. Salzmann CG, Ward MAH, Jacobs RMJ, et al. Interaction of tyrosine-, tryptophan-, and lysine- containing polypeptides with single-wall carbon nanotubes and its relevance for the rational design of dispersing agents. J Phys Chem C 2007;111:18520-4
74. Su ZD, Zhu SH, Donkor AD, et al. Controllable delivery of small-molecule compounds to targeted cells utilizing carbon nanotubes. J Am Chem Soc 2011;133:6874-7
75. Koolpe M, Burgess R, Dail M, Pasquale EB. EphB receptor-binding peptides identified by phage display enable design of an antagonist with ephrin-like affinity. J Biol Chem 2005;280:17301-11
76. Wheate NJ, Walker S, Craig GE, Oun R. The status of platinum anticancer drugs in the clinic and in clinical trials. Dalton T 2010;39:8113-27
77. Tripisciano C, Kraemer K, Taylor A, Borowiak-Palen E. Single-wall carbon nanotubes based anticancer drug delivery system. Chem Phys Lett 2009;478:200-5
78. Guven A, Rusakova IA, Lewis MT, Wilson LJ. Cisplatin@US-tube carbon nanocapsules for enhanced chemotherapeutic delivery. Biomaterials 2012;33:1455-61
79. Raoof M, Cisneros BT, Guven A, et al. Remotely triggered cisplatin release from carbon nanocapsules by radiofrequency fields. Biomaterials 2013;34:1862-9
80. Li J, Yap SQ, Yoong SL, et al. Carbon nanotube bottles for incorporation, release and enhanced cytotoxic effect of cisplatin. Carbon 2012;50:1625-34
81. Li J, Yap SQ, Chin CF, et al. Platinum (IV) prodrugs entrapped within multiwalled carbon nanotubes: selective release by chemical reduction and hydrophobicity reversal. Chem Sci 2012;3:2083-7
82. Yoong SL, Wong BS, Zhou QL, et al. Enhanced cytotoxicity to cancer cells by mitochondria-targeting MWCNTs containing platinum(IV) prodrug of cisplatin. Biomaterials 2014;35:748-59
83. Hampel S, Kunze D, Haase D, et al. Carbon nanotubes filled with a chemotherapeutic agent: a nanocarrier mediates inhibition of tumor cell growth. Nanomedicine 2008;3:175-82
84. Wu LL, Man CJ, Wang H, et al. PEGylated multi-walled carbon nanotubes for encapsulation and sustained release of oxaliplatin. Pharm Res 2013;30:412-23
85. Wu CH, Cao C, Kim JH, et al. Trojan-horse nanotube on-command intracellular drug delivery. Nano Lett 2012;12:5475-80
86. Rhen T, Cidlowski JA. Antiinflammatory action of glucocorticoids - New mechanisms for old drugs. N Engl J Med 2005;353:1711-23
87. Luo XL, Matranga C, Tan SS, et al. Carbon nanotube nanoreservior for controlled release of anti-inflammatory dexamethasone. Biomaterials 2011;32:6316-23
88. Sanz V, Tilmacîu C, Soula B, et al. Chloroquine-enhanced gene delivery mediated by carbon nanotubes. Carbon 2011;49:5348-58
89. Singh R, Mehra NK, Jain V, Jain NK. Gemcitabine-loaded smart carbon nanotubes for effective targeting to cancer cells. J Drug Target 2013;21:581-92
90. Li J, Pant A, Chin CF, et al. In vivo biodistribution of platinum-based drugs encapsulated into multi-walled carbon nanotubes. Nanomedicine 2014;10:1465-75
91. Pascu SI, Arrowsmith RL, Bayly SR, et al. Towards nanomedicines: design protocols to assemble, visualize and test carbon nanotube probes for multimodality biomedical imaging. Philos T Roy Soc A 2010;368:3683-712
92. 2@US-tube nanocapsules: A new X-ray contrast-agent design. Adv Mater 2007;19:573-6
93. Mackeyev YA, Marks JW, Rosenblum MG, Wilson LJ. Stable containment of radionuclides on the nanoscale by cut single-wall carbon nanotubes. J Phys Chem B 2005;109:5482-4
94. Hong SY, Tobias G, Al-Jamal KT, et al. Filled and glycosylated carbon nanotubes for in vivo radioemitter localization and imaging. Nat Mater 2010;9:485-90
95. Shao LD, Tobias G, Huh Y, Green MLH. Reversible filling of single walled carbon nanotubes opened by alkali hydroxides. Carbon 2006;44:2855-8
96. Tobias G, Ballesteros B, Green MLH. Carbon nanocapsules: blocking materials inside carbon nanotubes. Phys Status Solidi C 2010;7:2739-42
97. Ballesteros B, Tobias G, Ward MAH, Green MLH. Quantitative assessment of the amount of material encapsulated in filled carbon nanotubes. J Phys Chem C 2009;113:2653-6
98. 211AtCl@US-tube nanocapsules: A new concept in radiotherapeutic-agent design. Small 2007;3:1496-9
99. Rivera EJ, Tran LA, Hernandez-Rivera M, et al. Bismuth@US-tubes as a potential contrast agent for X-ray imaging applications. J Mater Chem B 2013;1:4792-800
100. Rivera EJ, Sethi R, Qu FF, et al. Nitroxide radicals@US-tubes: new spin labels for biomedical applications. Adv Funct Mater 2012;22:3691-8
101. Sethi R, Mackeyev Y, Wilson LJ. The Gadonanotubes revisited: a new frontier in MRI contrast agent design. Inorg Chim Acta 2012;393:165-72
102. Ma Q, Jebb M, Tweedle MF, Wilson LJ. The gadonanotubes: structural origin of their high-performance MRI contrast agent behavior. J Mater Chem B 2013;1:5791-7
103. Law JJ, Guven A, Wilson LJ. Relaxivity enhancement of aquated tris(β-diketonate) gadolinium(III) chelates by confinement within ultrashort singlewalled carbon nanotubes. Contrast Media Mol I 2014;doi: 10.1002/cmmi.603
104. Tran LA, Hernandez-Rivera M, Berlin AN, et al. The use of gadolinium-carbon nanostructures to magnetically enhance stem cell retention for cellular cardiomyoplasty. Biomaterials 2014;35:720-6
105. Tang AM, Ananta JS, Zhao H, et al. Cellular uptake and imaging studies of gadolinium-loaded single-walled carbon nanotubes as MRI contrast agents. Contrast Media Mol I 2011;6:93-9
106. Sitharaman B, Van Der Zande M, Ananta JS, et al. Magnetic resonance imaging studies on gadonanotubereinforced biodegradable polymer nanocomposites. J Biomed Mater Res Part A 2010;93A:1454-62
107. van der Zande M, Sitharaman B, Walboomers XF, et al. In vivo magnetic resonance imaging of the distribution pattern of gadonanotubes released from a degrading poly(lactic-co-glycolic acid) scaffold. Tissue Eng Part C-Methods 2011;17:19-26
108. Cisneros BT, Law JJ, Matson ML, et al. Stable confinement of positron emission tomography and magnetic resonance agents within carbon nanotubes for bimodal imaging. Nanomedicine 2014;1-11
109. Monch I, Leonhardt A, Meye A, et al. Synthesis and characteristics of Fe-filled multi-walled carbon nanotubes for biomedical application. In: meyer E, Hegner M, Gerber C, Guntherodt HJ, editors. Proceedings of the international conference on nanoscience and technology. Journal of Physics Conference Series. 61 Iop Publishing Ltd; Bristol: 2007. p. 820-4
110. Ding XF, Singh R, Burke A, et al. Development of iron-containing multiwalled carbon nanotubes for MR-guided laser-induced thermotherapy. Nanomedicine 2011;6:1341-52
111. Marega R, De Leo F, Pineux F, et al. Functionalized Fe-filled multiwalled carbon nanotubes as multifunctional scaffolds for magnetization of cancer cells. Adv Funct Mater 2013;23:3173-84
112. 4-filled carbon nanotubes for cancertargeted imaging and magnetically guided drug delivery. Langmuir 2012;28:16469-76
113. Nanotechnology in medical applications: The global market. BCC Research 2012: Report Code: HLC069B
114. Cancer fact sheet no. 297. World Health Organization 2014
115. Hilder TA, Hill JM. Probability of encapsulation of paclitaxel and doxorubicin into carbon nanotubes. Micro Nano Lett 2008;3:41-9
116. Sitharaman B, Kissell KR, Hartman KB, et al. Superparamagnetic gadonanotubes are high-performance MRI contrast agents. Chem Commun 2005;3915-17
117. Hashimoto A, Yorimitsu H, Ajima K, et al. Selective deposition of a gadolinium(III) cluster in a hole opening of single-wall carbon nanohorn. P Natl Acad Sci USA 2004;101:8527-30
118. Weissker U, Hampel S, Leonhardt A, Buchner B. Carbon nanotubes filled with ferromagnetic materials. Materials 2010;3:4387-427
119. Monch I, Meye A, Leonhardt A, et al. Ferromagnetic filled carbon nanotubes and nanoparticles: synthesis and lipid-mediated delivery into human tumor cells. J Magn Magn Mater 2005;290:276-8